Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients
Clinical trial NCT03282643 · COMPLETED
Trial details
- NCT number
- NCT03282643
- Sponsor
- Capital Medical University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-16
- Primary completion
- 2018-06-30
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.